About this Journal
Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research articles and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. The journal welcomes articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology, that provide new insights into the treatment of cardiovascular diseases, including acute coronary syndrome, arrhythmias, atherosclerosis, coagulation and thrombosis, diabetic cardiovascular disease, systolic and diastolic heart failure, hyperlipidemia, hypertension, and ischemic heart disease.
Cardiovascular Therapeutics is archived in Portico, which provides permanent archiving for electronic scholarly journals, as well as via the LOCKSS initiative. It operates a fully open access publishing model which allows open global access to its published content. This model is supported through Article Processing Charges. For more information on Article Processing charges in general, click here.
Cardiovascular Therapeutics is included in many leading abstracting and indexing databases. For a complete list, click here.
The most recent Impact Factor for Cardiovascular Therapeutics is 1.728 according to the 2017 Journal Citation Reports released by Clarivate Analytics in 2018. The journal’s most recent CiteScore is 1.55 according to the CiteScore 2017 metrics released by Scopus.
Content published prior to 2019 is hosted on the Wiley Online Library.
The Wiley Hindawi Partnership
This journal is published by Hindawi as part of a publishing collaboration with John Wiley & Sons, Inc. It is a fully Open Access journal produced under the Hindawi and Wiley brands. For more information please click here.